$OWL

BLUE OWL CAPITAL INC.

0
1
3

No SEC Form 4 filings for $OWL in the last 30 days.

See all $OWL insider activity →
High

Monday's Stock to Watch: Oracle, Blue Owl, and Apollo

Oracle (ORCL) announced an additional $700M restructuring charge due to layoffs, potentially impacting its stock. Blue Owl (OWL) saw a 10.81% drop in stock value, closing at $10.56, amid loan write-down concerns. Apollo (APO) is in talks to acquire J&J’s (JNJ) orthopedics unit, with mixed performance in the medical devices sector.

Blue Owl (NYSE: OWL) insider sells derivative tied to family trust's future gains

Blue Owl Co-President Marc Zahr transferred Blue Owl Operating Group Units to a family trust and sold a $14.9M derivative tied to future gains of these units, according to a Form 4 filing. The derivative agreement grants the trust rights to future appreciation above a $100K hurdle on specified Blue Owl interests, with settlement in 2033 or upon Zahr's death. Zahr disclaims beneficial ownership of the trust's securities except for pecuniary interest.

Monday's Stock to Watch: Oracle, Blue Owl, and Apollo

Oracle (ORCL) announced an additional $700M restructuring charge, potentially impacting shares. Blue Owl (OWL) underperformed, losing 10.81%, amid loan write-down concerns. Apollo (APO) is in talks to acquire J&J's (JNJ) orthopedics unit, while Stryker (SYK) and Medtronic (MDT) show mixed performance.

OWL sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 4 news stories mentioning OWL (BLUE OWL CAPITAL INC.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 3 bearish.

Recent OWL coverage spans corporate actions, ipo and market movers.

What's driving OWL

AlphAI scores every news story that mentions OWL with an AI model for sentiment and relevance, and aggregates insider trades from BLUE OWL CAPITAL INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $OWL

Score
$ORCLHighAI 8/10

Monday's Stock to Watch: Oracle, Blue Owl, and Apollo

Oracle (ORCL) announced an additional $700M restructuring charge due to layoffs, potentially impacting its stock. Blue Owl (OWL) saw a 10.81% drop in stock value, closing at $10.56, amid loan write-down concerns. Apollo (APO) is in talks to acquire J&J’s (JNJ) orthopedics unit, with mixed performance in the medical devices sector.

$OWLLow

Blue Owl (NYSE: OWL) insider sells derivative tied to family trust's future gains

Blue Owl Co-President Marc Zahr transferred Blue Owl Operating Group Units to a family trust and sold a $14.9M derivative tied to future gains of these units, according to a Form 4 filing. The derivative agreement grants the trust rights to future appreciation above a $100K hurdle on specified Blue Owl interests, with settlement in 2033 or upon Zahr's death. Zahr disclaims beneficial ownership of the trust's securities except for pecuniary interest.

$ORCLHighAI 9/10

Monday's Stock to Watch: Oracle, Blue Owl, and Apollo

Oracle (ORCL) announced an additional $700M restructuring charge, potentially impacting shares. Blue Owl (OWL) underperformed, losing 10.81%, amid loan write-down concerns. Apollo (APO) is in talks to acquire J&J's (JNJ) orthopedics unit, while Stryker (SYK) and Medtronic (MDT) show mixed performance.

$OWLLow

How will private credit and equity stocks react to Fed rate hikes?

Private credit stocks like Blue Owl (OWL), KKR, Apollo, Blackstone, and Ares have dropped significantly, with OWL down 56% from its January high. The VanEck BDC Income ETF (BIZD) also fell over 4% from its August peak. Investors anticipate an 85% chance of a Fed rate hike, citing strong jobs data and elevated inflation. Higher rates and rising energy prices may increase default risks for these companies' portfolios.

OWL Stock Slips As Legal Probes Threaten Momentum

Blue Owl Capital Inc. (OWL) shares fell 3.78% to $10.43, extending a 15% decline over two weeks. The company generates strong cash flow, with $2.87B revenue and an 8.5% dividend yield, but faces legal probes and high leverage. Multiple firms are investigating potential corporate wrongdoing, increasing headline risk and volatility.

Blue Owl latest entrant into data center REIT race

Blue Owl Capital plans to form and IPO a data center REIT, seeded with a $6.5B portfolio. The company aims to raise funds for further acquisitions. Its shares rose over 1% on the news but are down 21% this year. Blue Owl manages $319B in assets, including Stack Infrastructure, and recently acquired Sila Realty Trust for $2.4B. The company also invested $3B in Meta's Hyperion data center project.

Blue Owl’s Loparex Slips Toward Bankruptcy After Failed Deal

Blue Owl Capital marked down loans tied to Loparex from $122.43M to $8.34M after a failed merger, pushing Loparex into forbearance. Loparex's second lien debt fell over 94%. Loparex represented less than 1% of OBDC's portfolio, but investor nerves persist due to valuation uncertainties in private credit.

$IRENHighAI 9/10

Blue Owl leads $2.4 billion IREN GPU financing at 9%

Blue Owl Capital (NYSE: OWL) led a $2.4 billion financing for IREN (NASDAQ: IREN) to purchase NVIDIA GPUs for its Mackenzie campus. The deal includes a $1.2 billion term loan and $1.2 billion in notes, both at 9% interest. IREN plans to use the funds for AI infrastructure expansion, with proceeds drawn as hardware is delivered.

$OWLMedAI 8/10

Blue Owl Plans Data Center REIT IPO with AI Boom

Blue Owl Capital plans to create a data center REIT and take it public, seeding it with $6.5B of its own assets. The company aims to raise funds through an IPO and additional share sales to expand its portfolio. Blue Owl's shares rose 1.2% on the news, despite a 21% decline this year. Global data center expenditure is projected to reach $1.2T by 2028, according to Bloomberg Intelligence.

Related tickers